About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6508531
Allelic
Composition
Cd4tm1(cre/ERT2)Thbu/Cd4+
Gfm1tm1c(EUCOMM)Wtsi/Gfm1tm1c(EUCOMM)Wtsi
Genetic
Background
involves: C57BL/6 * C57BL/6N * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd4tm1(cre/ERT2)Thbu mutation (0 available); any Cd4 mutation (83 available)
Gfm1tm1c(EUCOMM)Wtsi mutation (0 available); any Gfm1 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• differentiation of tamoxifen-treated nave T cells under Th17 cell-skewing conditions yields a reduced frequency of IL-17 expressing cells
• tamoxifen-induced mice show a modest increase in the proportion of single-positive CD8+ population in the thymus
• tamoxifen-induced mice show a modest increase in the proportion of single-positive CD8+ population in the thymus
• tamoxifen-treated mice show significant protection from the development of experimental autoimmune encephalomyelitis (EAE), with mice showing lower numbers and percentages of MOG-specific IL-17 and IFN-gamma-producing Th cells in the central nervous system

hematopoietic system
• differentiation of tamoxifen-treated nave T cells under Th17 cell-skewing conditions yields a reduced frequency of IL-17 expressing cells
• tamoxifen-induced mice show a modest increase in the proportion of single-positive CD8+ population in the thymus
• tamoxifen-induced mice show a modest increase in the proportion of single-positive CD8+ population in the thymus


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
06/12/2024
MGI 6.13
The Jackson Laboratory